comparing heart rate and blood pressure with inhaled dexmedetomidine and magnesium sulfate in surgeries under general anesthesia
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/02/063147
- Lead Sponsor
- Dr Kiran A V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA I and II
Mallampati grade I and II
BMI 18.5 to 24.9 kg per meter square
patients willing to give informed consent
Exclusion Criteria
history of upper respiratory tract infection in previous 2 weeks
baseline heart rate less than 60 beats per minute
baseline systolic blood pressure less than 60 mm Hg
patients on any medications altering study parameters
pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain nebulized dexmedetomidine's hemodynamic effects during intubation?
How does nebulized magnesium sulfate compare to intravenous agents in managing intubation stress response?
Are there specific biomarkers that predict differential response to nebulized alpha-2 agonists versus magnesium in surgical patients?
What adverse events are associated with nebulized alpha-2 adrenergic agonist use in perioperative settings?
How do nebulized formulations of dexmedetomidine and magnesium sulfate compare to other inhaled anesthetic adjuncts in attenuating laryngoscopy-induced hypertension?